YAP1 and neoplasm: Studies have shown that YAP1 can recruit M2 macrophages, bone-marrow-derived suppressor cells, and regulatory T cells, thereby inhibiting host-effector T cells in the tumor microenvironment and further leading to cancer progression and drug resistance [31].